Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure

NCT07238452 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07238452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
January 1, 2033
Enrollment
1,050 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), heart failure with reduced ejection fraction